© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Belite Bio, Inc (BLTE) shows an Average True Range (ATR) of 8.67 and an Enterprise Value of 1.02B. Its average trading volume over the past 3 months is 230.67K, indicating liquidity. These fundamental metrics provide insight into BLTE's underlying financial health and market activity.
| ATR | 8.67 |
| Enterprise Value | 1.02B |
| Avg Vol (3 Months) | 230.67K |
| Avg Vol (10 Days) | 297.99K |
Belite Bio, Inc (BLTE) technical indicators as of March 4, 2026: the SMA 20 is 4.9%, SMA 50 at 13.15%, and SMA 200 at 85.16%. The RSI 14 value is 64.81, suggesting its current momentum. These technical analysis signals help assess BLTE's price trends and potential future movements.
| SMA 20 | 4.9% |
| SMA 50 | 13.15% |
| SMA 200 | 85.16% |
| RSI 14 | 64.81 |
Belite Bio, Inc (BLTE) stock performance overview as of March 4, 2026: The 52-week high is $200 (currently -5.72% below), and the 52-week low is $49 (currently 284.8% above). Over the past year, BLTE's performance is 201.68%, compared to the S&P 500's 12.91% change.
| 52-Week High | 200 |
| 52-Week High Chg | -5.72% |
| 52-Week Low | 49 |
| 52-Week Low Chg | +284.80% |
| S&P 500 52-Week Chg | 12.91% |
According to market data, Belite Bio, Inc (BLTE) stock's recent performance metrics show that over the last month, BLTE is 3.76%, with a Year-to-Date (YTD) performance of 0.03%. Over the past year, the stock has seen a 201.68% change. These figures summarize BLTE's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 192.28 | 200 | 200 | 200 | 200 | 200 |
| Low | 167.59 | 165.51 | 129 | 62.18 | 49 | 146.06 |
| Performance | +3.37% | +3.76% | +82.43% | +161.03% | +201.68% | +0.03% |
According to current financial data, BLTE stock's P/E (TTM) ratio is -92.11, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for BLTE, including P/S (N/A), P/B (20.97), and P/FCF (N/A), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | BLTE | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -92.11 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 20.97 | -603.44 | 7.03 | 4.87 |
| P/FCF (TTM) | N/A | N/A | -228.24 | 33.92 |